Thyroid and Cardiovascular Disease
Anne Rentoumis Cappola(University Hospital of Bern), Ari J. Wassner(Boston Children's Hospital), Kaie Ojamaa(Feinstein Institute for Medical Research), Christina Ellervik(Boston Children's Hospital), Marco Medici(Radboud University Nijmegen), Cheryl L. McDonald(National Heart Lung and Blood Institute), George Sopko(National Heart Lung and Blood Institute), Amir Lerman(Mayo Clinic in Arizona), Paul W. Ladenson(Johns Hopkins University), Steven Goldman(University of Arizona), Peter J. Kudenchuk(Public Health – Seattle & King County), Francesco S. Celi(UConn Health), Anthony N. Hollenberg(Boston Medical Center), Glenn I. Fishman(New York University), Ayako Makino, David S. Cooper(Johns Hopkins University), Robin P. Peeters(Unknown), Giorgio Iervasi(Istituto di Fisiologia Clinica), Alessandro Pingitore, Samia Mora(Brigham and Women's Hospital), Wolfgang H. Dillman, Salman Razvi(Newcastle University), Akshay S. Desai(Brigham and Women's Hospital), A. Martin Gerdes(University of South Dakota), Carolyn Y. Ho(Brigham and Women's Hospital), Debra Egan(National Institutes of Health), Lawton S. Cooper(Atrium Health Wake Forest Baptist)
Cited by 123
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
|Thyroid|2009|6.7k
Part 8: Adult Advanced Cardiovascular Life Support
|Circulation|2010|1.6k
Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease
|New England Journal of Medicine|2018|1.6k